Tumor homografts are transplants of GEMM tumors into immunocompetent syngeneic hosts. Our skin tumor homografts preserve original GEMM tumo histo- and molecular pathology as well as a relevant TME and are ideally positioned to test novel cross reactive or surrogate agents as well as combination strategies with checkpoint inhibitors.
MODEL NUMBER | ORIGINAL GEMM MUTATION | # per page |
---|---|---|
mSK6005 | ApcMin/+ | CLICK TO VIEW |
Already Registered? Login
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy